Clinical Letter: Rapidly Progressive <scp>TEN</scp> Secondary to Nivolumab and Relatlimab in a Patient With Metastatic Gastric Mucosal Melanoma

The data that support the findings of this report are available from the corresponding author (S.C.) upon reasonable request.

Authors

Institutions

Publication Details

Journal
Australasian Journal of Dermatology
Published
2025-10-21
DOI
https://doi.org/10.1111/ajd.14618
Citations
1
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Letter: Rapidly Progressive TEN Secondary to Nivolumab and Relatlimab in a Patient With Metastatic Gastric Mucosal Melanoma

Linda Chan, Peter M. Ferguson, Siew F Chan
1 citations
Australasian Journal of Dermatology
Drug-Induced Adverse Reactions
1.39
article

Clinical Letter: Rapidly Progressive TEN Secondary to Nivolumab and Relatlimab in a Patient With Metastatic Gastric Mucosal Melanoma

Linda Chan, Peter M. Ferguson, Siew F Chan
article en
1 citations

Abstract

The data that support the findings of this report are available from the corresponding author (S.C.) upon reasonable request.

Australasian Journal of DermatologyVol. 66(8)
The University of Sydney (AU), New South Wales Department of Health (AU), Concord Repatriation General Hospital (AU)
Openalex Percentile: Top 15%
Drug-Induced Adverse Reactions
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.